Dendritic Polyglycerol Sulfate for Therapy and Diagnostics
AbstractDendritic polyglycerol sulfate (dPGS) has originally been investigated as an anticoagulant to potentially substitute for the natural glycosaminoglycan heparin. Compared to unfractionated heparin, dPGS possesses lower anticoagulant activity but a much higher anticomplementary effect. Since coagulation, complement activation, and inflammation are often present in the pathophysiology of numerous diseases, dPGS polymers with both anticoagulant and anticomplementary activities represent promising candidates for the development of polymeric drugs of nanosized architecture. In this review, we describe the nanomedical applications of dPGS based on its anti-inflammatory activity. Furthermore, the application of dPGS as a carrier molecule for diagnostic molecules and therapeutic drugs is reviewed, based on the ability to target tumors and localize in tumor cells. Finally, the application of dPGS for inhibition of virus infections is described. View Full-Text
Share & Cite This Article
Rades, N.; Licha, K.; Haag, R. Dendritic Polyglycerol Sulfate for Therapy and Diagnostics. Polymers 2018, 10, 595.
Rades N, Licha K, Haag R. Dendritic Polyglycerol Sulfate for Therapy and Diagnostics. Polymers. 2018; 10(6):595.Chicago/Turabian Style
Rades, Nadine; Licha, Kai; Haag, Rainer. 2018. "Dendritic Polyglycerol Sulfate for Therapy and Diagnostics." Polymers 10, no. 6: 595.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.